Derivation Web

source_05036865ab8e4497

{"contradictions": ["Receipt 1 shows a pharmacologic adjunct (dapagliflozin) preserves training adaptations, while Receipt 2 reports a damage/injury-protection benefit that does not translate into improved performance, highlighting a split between protective and adaptive endpoints under the same metformin + exercise anchor."], "limitations": ["This is an agent-assisted alpha memo, not a PRISMA-com…